Research map: Lack of resolution of inflammation marks malignant pleural mesothelioma progression

Back to the article

Papers in this map

  1. Tumors: Wounds That Do Not Heal · Jeffrey S. Flier · 1986 · 4425 citations · Cited by this paper
  2. KLF5 promotes tumor proliferation and oxaliplatin resistance via chromatin remodeling in KRAS-mutated colorectal cancer · 2025 · Related
  3. Arachidonic acid as a bioactive molecule · ALAN R. BRASH · 2001 · 574 citations · Cited by this paper
  4. Immunotherapy resistance and strategies in malignant pleural mesothelioma · 2026 · Related
  5. Bioactive Lipids and Chronic Inflammation: Managing the Fire Within · Valerio Chiurchiù · 2018 · 435 citations · Cited by this paper
  6. Effects of FAP+ cancer-associated fibroblasts on anti-PD-1 immunotherapy and CD4+ T cell polarization in gastric cancer · 2025 · Related
  7. Carcinogenesis: Failure of resolution of inflammation? · Anna Fishbein · 2020 · 206 citations · Cited by this paper
  8. TRAP1 ablation improves mitochondrial cristae and oxidative phosphorylation in pancreatic cancer stem cells · 2026 · Related
  9. SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells · Claudia Canino · 2011 · 203 citations · Cited by this paper
  10. Novel anti-tumor strategies: targeting the crosstalk between cancer stem cells and cancer-associated fibroblasts to resist drug resistance · 2026 · Related
  11. The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification · Jennifer L. Sauter · 2022 · 203 citations · Cited by this paper
  12. Unveiling the role of UGT enzymes in chemoresistance: a path to enhanced cancer pharmacotherapy · 2026 · Related
  13. The Atlas of Inflammation Resolution (AIR) · Charles Nicholas Serhan · 2020 · 178 citations · Cited by this paper
  14. Targeting tumor-draining lymph node to overcome resistance to cancer immunotherapy: an update · 2025 · Related
  15. Update on biology and management of mesothelioma · Rachelle Asciak · 2021 · 78 citations · Cited by this paper
  16. Corosolic acid increases the therapeutic effect of cisplatin on gastric cancer by regulating Gpx4-dependent ferroptosis · 2025 · Related
  17. Epidemiology and Clinical Aspects of Malignant Pleural Mesothelioma · Fraser Brims · 2021 · 75 citations · Cited by this paper
  18. ROS1 mutations promote an immunosuppressive tumor microenvironment via MYC to confer immune evasion in head and neck cancer · 2025 · Related
  19. Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic Opportunities · Margot Lavy · 2021 · 66 citations · Cited by this paper
  20. Roles and potential applications of non-coding RNAs in cancer treatment with immune checkpoint inhibitors and immunomodulatory therapies · 2026 · Related
  21. Wnt/IL‐1β/IL‐8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5 · Vladan Milošević · 2019 · 48 citations · Cited by this paper
  22. Expert consensus report on lipid mediators: Role in resolution of inflammation and muscle preservation · Charles Nicholas Serhan · 2024 · 39 citations · Cited by this paper
  23. Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: Result in a cohort of 203 resection specimens · Aneil A. Mujoomdar · 2010 · 36 citations · Cited by this paper
  24. BAP1 forms a trimer with HMGB1 and HDAC1 that modulates gene × environment interaction with asbestos · Flavia Novelli · 2021 · 34 citations · Cited by this paper
  25. Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma · Bruno Giotti · 2024 · 33 citations · Cited by this paper
  26. HMGB1 released by mesothelial cells drives the development of asbestos-induced mesothelioma · Joelle Sacks Suarez · 2023 · 31 citations · Cited by this paper
  27. Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013–2017: A nationwide CAS registry analysis from the I-O Optimise initiative · Paul Baas · 2021 · 27 citations · Cited by this paper
  28. Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma · Mario Cioce · 2021 · 25 citations · Cited by this paper
  29. Clinical and Pathologic Phenotyping of Mesotheliomas Developing in Carriers of Germline BAP1 Mutations · Michele Carbone · 2025 · 23 citations · Cited by this paper
  30. A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers · Lorenzo Magrassi · 2024 · 21 citations · Cited by this paper
  31. Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesothelioma · Michele Carbone · 2023 · 19 citations · Cited by this paper
  32. The Significance of Aldehyde Dehydrogenase 1 in Cancers · Anh L. Nguyen · 2024 · 19 citations · Cited by this paper
  33. CF Patients’ Airway Epithelium and Sex Contribute to Biosynthesis Defects of Pro-Resolving Lipids · Mickaël Shum · 2022 · 18 citations · Cited by this paper
  34. Single-cell transcriptomic analysis of human pleura reveals stromal heterogeneity and informs in vitro models of mesothelioma · Joanna Obacz · 2024 · 15 citations · Cited by this paper
  35. Updates in Staging and Management of Malignant Pleural Mesothelioma · Andrea Wolf · 2020 · 11 citations · Cited by this paper
  36. Cell-Type-Specific Gene Regulatory Networks of Pro-Inflammatory and Pro-Resolving Lipid Mediator Biosynthesis in the Immune System · Matti Hoch · 2023 · 10 citations · Cited by this paper
  37. Malignant Pleural Mesothelioma: A 2025 Update · Giuseppe Cardillo · 2025 · 8 citations · Cited by this paper
  38. Immunotherapy advances in pleural mesothelioma · Annie Li Zhang · 2026 · 1 citation · Cited by this paper
  39. Untitled · Cited by this paper

Source: OpenAlex (CC0)